Lindsay K. Blackwood serves as Senior Vice President, General Counsel, and Corporate Secretary at Integer Holdings Corporation, a leading global manufacturer of medical device components and assemblies. In this pivotal role, she oversees all legal matters, including corporate governance, regulatory compliance, mergers and acquisitions, intellectual property, and risk management. Lindsay ensures the company's adherence to complex FDA regulations, securities laws, and international standards, while also serving as Corporate Secretary to the Board of Directors, facilitating strategic decision-making and shareholder relations. With over 25 years of experience in the medical device and healthcare industries, Lindsay began her career as a corporate associate at the international law firm Bryan Cave LLP, where she advised on mergers, acquisitions, and securities transactions. She later held progressive leadership roles at Mallinckrodt Pharmaceuticals and Covidien plc (now part of Medtronic), culminating in her position as Vice President and Associate General Counsel. There, she managed global legal teams, navigated high-stakes litigation, and supported multibillion-dollar deals, including the spin-off of Covidien's pharmaceuticals business. Lindsay's notable achievements include spearheading Integer's successful integration of key acquisitions, such as the 2022 purchase of InPulse Medical, and enhancing the company's ESG initiatives through robust governance frameworks. A recognized leader in her field, she has been instrumental in fostering a culture of compliance and innovation at Integer, contributing to the company's sustained growth and market leadership in the medtech sector.